{"id":54213,"date":"2023-02-23T23:06:21","date_gmt":"2023-02-23T22:06:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/"},"modified":"2023-02-23T23:06:21","modified_gmt":"2023-02-23T22:06:21","slug":"sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/","title":{"rendered":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023"},"content":{"rendered":"
\n

BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–$SOPH<\/a>–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. EST \/ 2:00 p.m. CET.\n<\/p>\n

<\/a><\/p>\n

\nThe call will be webcast live on the SOPHiA GENETICS Investor Relations website<\/a>. Additionally, a replay will be available on the website after its completion.\n<\/p>\n

\nAbout SOPHiA GENETICS<\/b>\n<\/p>\n

\nSOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM\u2122 Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM\u2122 Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM<\/a>, or connect on Twitter<\/a>, LinkedIn<\/a>, <\/b>Facebook<\/a>, and Instagram<\/a>. Where others see data, we see answers.<\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor:
\n
<\/strong>Katherine Bailon
\n
VP, Investor Relations
\n
ir@sophiagenetics.com<\/a>\n<\/p>\n

\nMedia:
\n
<\/strong>Nick Puleo
\n
npuleo@comsint.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–$SOPH–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA GENETICS will host a conference call to discuss its financial results … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54213","6":"format-standard","7":"category-industry"},"yoast_head":"\nSOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–$SOPH–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA GENETICS will host a conference call to discuss its financial results ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-23T22:06:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023\",\"datePublished\":\"2023-02-23T22:06:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/\"},\"wordCount\":229,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230223005992\\\/en\\\/1681846\\\/21\\\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/\",\"name\":\"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230223005992\\\/en\\\/1681846\\\/21\\\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg\",\"datePublished\":\"2023-02-23T22:06:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230223005992\\\/en\\\/1681846\\\/21\\\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230223005992\\\/en\\\/1681846\\\/21\\\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/","og_locale":"en_US","og_type":"article","og_title":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend","og_description":"BOSTON & LAUSANNE, Switzerland–(BUSINESS WIRE)–$SOPH–SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the fourth quarter and full year of fiscal 2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA GENETICS will host a conference call to discuss its financial results ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-23T22:06:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023","datePublished":"2023-02-23T22:06:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/"},"wordCount":229,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/","url":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/","name":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg","datePublished":"2023-02-23T22:06:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230223005992\/en\/1681846\/21\/SOPHiA_GENETICS_Stacked_RGB_%285%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sophia-genetics-to-announce-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2022-on-march-7-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54213"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54213\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}